Monday, October 19, 2015

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment



data:image/jpeg;base64,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


Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Tresiba® (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba® is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba® provides a long duration of action beyond 42 hours. While patients are encouraged to take their insulin at the same time each day, Tresiba® allows patients to dose at any time of the day.

"Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes, and we are proud to bring forward the first new basal insulin molecule to be approved by the FDA in 10 years," said Jesper Høiland, president of Novo Nordisk in the U.S. and executive vice president of Novo Nordisk A/S. "Novo Nordisk is excited to launch Tresiba® in the United States in the first quarter of 2016."

Ref : http://www.diapedia.org/management/insulin-degludec 

No comments: